Immunoadsorption in patients with haemolytic uraemic syndrome
- PMID: 22325656
- DOI: 10.1016/S0140-6736(12)60228-1
Immunoadsorption in patients with haemolytic uraemic syndrome
Comment on
-
Treatment of severe neurological deficits with IgG depletion through immunoadsorption in patients with Escherichia coli O104:H4-associated haemolytic uraemic syndrome: a prospective trial.Lancet. 2011 Sep 24;378(9797):1166-73. doi: 10.1016/S0140-6736(11)61253-1. Epub 2011 Sep 2. Lancet. 2011. PMID: 21890192 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
